Skip to main content Accessibility help
×
Home

Periodontal disease and effects of antipsychotic medications in patients newly diagnosed with schizophrenia: a population-based retrospective cohort

  • Kai-Fang Hu (a1) (a2), Pei-Shan Ho (a3) (a4), Yu-Hsiang Chou (a2), Jui-Hsiu Tsai (a5) (a6), Chung-Hung Richard Lin (a7) and Hung-Yi Chuang (a8) (a9)...

Abstract

Aim

Compared with the general population, individuals with schizophrenia have a higher risk of periodontal disease, which can potentially reduce their life expectancy. However, evidence for the early development of periodontal disease in schizophrenia is scant. The current study investigated risk factors for periodontal disease in patients newly diagnosed with schizophrenia.

Methods

We identified a population-based cohort of patients in Taiwan with newly diagnosed schizophrenia who developed periodontal disease within 1 year of their schizophrenia diagnosis. Treatment with antipsychotics and other medications was categorised according to medication type and duration, and the association between medication use and the treated periodontal disease was assessed through logistic regression.

Results

Among 3610 patients with newly diagnosed schizophrenia, 2373 (65.7%) had an incidence of treated periodontal disease during the 1-year follow-up. Female sex (adjusted odds ratios [OR] 1.40; 95% confidence interval [CI] 1.20–1.63); young age (adjusted OR 0.99; 95% CI 0.98–0.99); a 2-year history of periodontal disease (adjusted OR 2.45; 95% CI 1.84–3.26); high income level (adjusted OR 2.24; 95% CI 1.64–3.06) and exposure to first-generation (adjusted OR 1.89; 95% CI 1.54–2.32) and secondary-generation (adjusted OR 1.33; 95% CI 1.11–1.58) antipsychotics, anticholinergics (adjusted OR 1.24; 95% CI 1.03–1.50) and antihypertensives (adjusted OR 1.91; 95% CI 1.64–2.23) were independent risk factors for periodontal disease. Hyposalivation – an adverse effect of first-generation antipsychotics (FGAs) (adjusted OR 2.00; 95% CI 1.63–2.45), anticholinergics (adjusted OR 1.27; 95% CI 1.05–1.53) and antihypertensives (adjusted OR 1.90; 95% CI 1.63–2.22) – was associated with increased risk of periodontal disease. Therefore, hypersalivation due to FGA use (adjusted OR 0.72; 95% CI 0.59–0.88) was considered a protective factor.

Conclusions

The current study highlights that early prevention of periodontal disease in individuals with schizophrenia is crucial. Along with paying more attention to the development of periodontal disease, assessing oral health regularly, helping with oral hygiene, and lowering consumption of sugary drinks and tobacco, emphasis should also be given by physicians to reduce the prescription of antipsychotics to the extent possible under efficacious pharmacotherapy for schizophrenia.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Periodontal disease and effects of antipsychotic medications in patients newly diagnosed with schizophrenia: a population-based retrospective cohort
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Periodontal disease and effects of antipsychotic medications in patients newly diagnosed with schizophrenia: a population-based retrospective cohort
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Periodontal disease and effects of antipsychotic medications in patients newly diagnosed with schizophrenia: a population-based retrospective cohort
      Available formats
      ×

Copyright

This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.

Corresponding author

Author for correspondence: Jui-Hsiu Tsai, E-mail: u105803001@kmu.edu.tw

References

Hide All
Albandar, JM (2002) Global risk factors and risk indicators for periodontal disease. Periodontology 2000 29, 177206.
Angelillo, IF, Nobile, CG, Pavia, M, De Fazio, P, Puca, M and Amati, A (1995) Dental health and treatment needs in institutionalised psychiatric patients in Italy. Community Dentistry and Oral Epidemiology 23, 360364.
Arnaiz, A, Zumárraga, M, Díez-Altuna, I, Uriarte, JJ, Moro, J and Pérez-Ansorena, MA (2011) Oral health and the symptoms of schizophrenia. Psychiatry Research 188, 2428.
Carney, R, Cotter, J, Bradshaw, T, Firth, J and Yung, AR (2016) Cardiometabolic risk factors in young people at ultra-high risk for psychosis: a systematic review and meta-analysis. Schizophrenia Research 170, 290300.
Chu, KY, Yang, NP, Chou, P, Chiu, HJ and Chi, LY (2012) Comparison of oral health between inpatients with schizophrenia and disabled people or the general population. Journal of the Formosan Medical Association 111, 214219.
Cullinan, MP and Seymour, GJ (2013) Periodontal disease and systemic illness: will the evidence ever be enough? Periodontology 2000 62, 271286.
Dai, J, Li, Z and Rocke, D (2006) Hierarchical Logistic Regression Modeling with SAS GLIMMIX. Available at http://www.lexjansen.com/wuss/2006/Analytics/ANL-Dai.pdf (Accessed 18 November 2017).
Dumitrescu, AL, Dogaru, CB and Dogaru, CD (2008) Instability of self-esteem and affective lability as determinants of self-reported oral health status and oral health-related behaviors. The Journal of Contemporary Dental Practice 9, 3845.
Eltas, A, Kartalcı, S, Eltas, SD, Dündar, S and Uslu, MO (2013) An assessment of periodontal health in patients with schizophrenia and taking antipsychotic medication. International Journal of Dental Hygiene 11, 7883.
Friedlander, AH and Marder, SR (2002) The psychopathology, medical management and dental implications of schizophrenia. The Journal of the American Dental Association 133, 603610.
Genco, RJ and Borgnakke, WS (2013) Risk factors for periodontal disease. Periodontology 2000 62, 5994.
Gopalakrishnapillai, AC, Iyer, RR and Kalantharakath, T (2012) Prevalence of periodontal disease among inpatients in a psychiatric hospital in India. Special Care in Dentistry 32, 196204.
Gurbuz, O, Alatas, G, Kurt, E, Dogan, F and Issever, H (2011) Periodontal health and treatment needs among hospitalized chronic psychiatric patients in Istanbul, Turkey. Community Dental Health Journal 28, 6974.
Hashimoto, Y, Uno, J, Miwa, T, Kurihara, M, Tanifuji, H and Tensho, M (2012) Effects of antipsychotic polypharmacy on side-effects and concurrent use of medications in schizophrenic outpatients. Psychiatry and Clinical Neurosciences 66, 405510.
Hede, B (1995) Oral health in Danish hospitalized psychiatric patients. Community Dentistry and Oral Epidemiology 23, 4448.
Hirotomi, T, Yoshihara, A, Ogawa, H, Ito, K, Igarashi, A and Miyazaki, H (2006) A preliminary study on the relationship between stimulated saliva and periodontal conditions in community-dwelling elderly people. Journal of Dentistry 34, 692698.
Hu, KF, Chou, YH, Wen, YH, Hsieh, KP, Tsai, JH, Yang, P, Yang, YH and Lin, CR (2016) Antipsychotic medications and dental caries in newly diagnosed schizophrenia: a nationwide cohort study. Psychiatry Research 245, 4550.
Ji, S, Choi, YS and Choi, Y (2015) Bacterial invasion and persistence: critical events in the pathogenesis of periodontitis? Journal of Periodontal Research 50, 570585.
Kenkre, AM and Spadigam, AE (2000) Oral health and treatment needs in institutionalized psychiatric patients in India. Indian Journal of Dental Research 11, 511.
Kossioni, AE, Kossionis, GE and Polychronopoulou, A (2012) Oral health status of elderly hospitalised psychiatric patients. Gerodontology 29, 272283.
Lin, CR, Tsai, JH, Wu, SS, Chang, YP, Wen, YH, Liu, JS and Lung, FW (2018) Quantitative comorbidity risk assessment of dementia in Taiwan: a population-based cohort study. Medicine (Baltimore) 97, e0298.
Mitchell, AJ, Vancampfort, D, Sweers, K, van Winkel, R, Yu, W and De Hert, M (2013) Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders – a systematic review and meta-analysis. Schizophrenia Bulletin 39, 306318.
Mizutani, S, Ekuni, D, Tomofuji, T, Azuma, T, Kataoka, K, Yamane, M, Iwasaki, Y and Morita, M (2015) Relationship between xerostomia and gingival condition in young adults. Journal of Periodontal Research 50, 7479.
Morales-Chávez, MC, Rueda-Delgado, YM and Peña-Orozco, DA (2014) Prevalence of bucco-dental pathologies in patients with schizophrenic disorders. Journal of Clinical and Experimental Dentistry 6, e7e11.
Muench, J and Hamer, AM (2012) Adverse effects of antipsychotic medications. American Family Physician 81, 617622.
Nayak, SU, Singh, R and Kota, KP (2016) Periodontal health among non-hospitalized chronic psychiatric patients in Mangaluru City-India. Journal of Clinical and Diagnostic Research 10, ZC40ZC43.
Pihlstrom, BL, Michalowicz, BS and Johnson, NW (2005) Periodontal diseases. Lancet 366, 18091820.
Ramon, T, Grinshpoon, A, Zusman, SP and Weizman, A (2003) Oral health and treatment needs of institutionalized chronic psychiatric patients in Israel. European Psychiatry 18, 101105.
Scully, C and Bagan, JV (2004) Adverse drug reactions in the orofacial region. Critical Reviews in Oral Biology and Medicine 15, 221239.
Sekine, Y, Rikihisa, T, Ogata, H, Echizen, H and Arakawa, Y (1999) Correlations between in vitro affinity of antipsychotics to various central neurotransmitter receptors and clinical incidence of their adverse drug reactions. European Journal of Clinical Pharmacology 55, 583587.
Shetty, S and Bose, A (2014) Schizophrenia and periodontal disease: an oro-neural connection? A cross-sectional epidemiological study. Journal of Indian Society of Periodontology 18, 6973.
Tang, WK, Sun, FC, Unqvari, GS and O'Donnell, D (2004) Oral health of psychiatric in-patients in Hong Kong. International Journal of Social Psychiatry 50, 186191.
Teng, PR, Su, JM, Chang, WH and Lai, TJ (2011) Oral health of psychiatric inpatients: a survey of central Taiwan hospitals. General Hospital Psychiatry 33, 253259.
Thomson, WM, Sheiham, A and Spencer, AJ (2012) Sociobehavioral aspects of periodontal disease. Periodontology 2000 60, 5463.
Vinayak, V, Annigeri, RG, Patel, HA and Mittal, S (2013) Adverse effects of drugs on saliva and salivary glands. Journal of Orofacial Sciences 5, 1520.
Wagaiyu, EG and Ashley, FP (1991) Mouthbreathing, lip seal and upper lip coverage and their relationship with gingival inflammation in 11–14 year-old schoolchildren. Journal of Clinical Periodontology 18, 698702.
Wey, MC, Loh, S, Doss, JG, Abu Bakar, AK and Kisely, S (2016) The oral health of people with chronic schizophrenia: a neglected public health burden. Australian and New Zealand Journal of Psychiatry 50, 685694.

Keywords

Periodontal disease and effects of antipsychotic medications in patients newly diagnosed with schizophrenia: a population-based retrospective cohort

  • Kai-Fang Hu (a1) (a2), Pei-Shan Ho (a3) (a4), Yu-Hsiang Chou (a2), Jui-Hsiu Tsai (a5) (a6), Chung-Hung Richard Lin (a7) and Hung-Yi Chuang (a8) (a9)...

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed